| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absorption, Distribution, Metabolism, and Excretion of the Novel Helicase-Primase Inhibitor, Amenamevir (ASP2151), in Rodents
|
Ohtsu, Yoshiaki
|
|
2018
|
|
6 |
p. 693-706
|
artikel
|
| 2 |
Acknowledgements
|
|
|
2016
|
|
6 |
p. 655-657
|
artikel
|
| 3 |
Acknowledgement to Referees
|
|
|
|
|
6 |
p. 757-759
|
artikel
|
| 4 |
Acknowledgement to Referees
|
|
|
2017
|
|
6 |
p. 879-880
|
artikel
|
| 5 |
Acknowledgement to Referees
|
|
|
2018
|
|
6 |
p. 615-617
|
artikel
|
| 6 |
Acknowledgement to Referees
|
|
|
2019
|
|
6 |
p. 725-727
|
artikel
|
| 7 |
Acknowledgement to Referees
|
|
|
|
|
6 |
p. 707-709
|
artikel
|
| 8 |
Acknowledgement to Referees
|
|
|
|
|
6 |
p. 693-695
|
artikel
|
| 9 |
Acknowledgement to Referees
|
|
|
|
|
6 |
p. 615-617
|
artikel
|
| 10 |
Advances in Thiopurine Drug Delivery: The Current State-of-the-Art
|
Bayoumy, Ahmed B.
|
|
|
|
6 |
p. 743-758
|
artikel
|
| 11 |
Angiotensin Receptor Blocker Losartan Inhibits Spontaneous Motility of Isolated Human Ureter
|
Jankovic, Slobodan M.
|
|
2015
|
|
6 |
p. 835-838
|
artikel
|
| 12 |
A Physiologically Based Pharmacokinetic Model of Amiodarone and its Metabolite Desethylamiodarone in Rats: Pooled Analysis of Published Data
|
Lu, Jing-Tao
|
|
2015
|
|
6 |
p. 689-703
|
artikel
|
| 13 |
A Systematic Review of Multiple Linear Regression-Based Limited Sampling Strategies for Mycophenolic Acid Area Under the Concentration–Time Curve Estimation
|
Sobiak, Joanna
|
|
|
|
6 |
p. 721-742
|
artikel
|
| 14 |
Biodistribution and Pharmacokinetic Study of 3,3′ Diseleno Dipropionic Acid (DSePA), A Synthetic Radioprotector, in Mice
|
Gota, Vikram
|
|
2015
|
|
6 |
p. 839-844
|
artikel
|
| 15 |
Catechol-O-Methyltransferase and UDP-Glucuronosyltransferases in the Metabolism of Baicalein in Different Species
|
Zhang, Ruiya
|
|
2017
|
|
6 |
p. 981-992
|
artikel
|
| 16 |
Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine
|
Bohn, Jan-Paul
|
|
2019
|
|
6 |
p. 845-851
|
artikel
|
| 17 |
Clinical Pharmacokinetic and Pharmacodynamic Profile of Lenvatinib, an Orally Active, Small-Molecule, Multitargeted Tyrosine Kinase Inhibitor
|
Hussein, Ziad
|
|
2017
|
|
6 |
p. 903-914
|
artikel
|
| 18 |
Clinical Pharmacokinetics and Drug Interactions of Doravirine
|
Wilby, Kyle John
|
|
2018
|
|
6 |
p. 637-644
|
artikel
|
| 19 |
Clinical Pharmacokinetics of Vancomycin in Critically Ill Children
|
Sridharan, Kannan
|
|
2019
|
|
6 |
p. 807-816
|
artikel
|
| 20 |
Combined Effect of Inter- and Intrapatient Variability in Tacrolimus Exposure on Graft Impairment Within a 3-Year Period Following Kidney Transplantation: A Single-Center Experience
|
Stefanović, Nikola Z.
|
|
|
|
6 |
p. 749-760
|
artikel
|
| 21 |
Combined Semi-mechanistic Target-Mediated Drug Disposition and Pharmacokinetic–Pharmacodynamic Models of Alirocumab, PCSK9, and Low-Density Lipoprotein Cholesterol in a Pooled Analysis of Randomized Phase I/II/III Studies
|
Nolain, Patrick
|
|
|
|
6 |
p. 789-802
|
artikel
|
| 22 |
Comments on: “Population Pharmacokinetic Modeling of Olmesartan, the Active Metabolite of Olmesartan Medoxomil, in Patients with Hypertension”
|
Srinivas, Nuggehally R.
|
|
2017
|
|
6 |
p. 1019-1021
|
artikel
|
| 23 |
Comparison of In Vitro Corneal Permeation and In Vivo Ocular Bioavailability in Rabbits of Three Marketed Latanoprost Formulations
|
Chauchat, Laure
|
|
|
|
6 |
p. 633-645
|
artikel
|
| 24 |
Correction to: Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data
|
Kareva, Irina
|
|
|
|
6 |
p. 827
|
artikel
|
| 25 |
Current Regulation for Bioequivalence Evaluations of Generic Ophthalmic Dosage Forms in Japan
|
Myoenzono, Aya
|
|
|
|
6 |
p. 697-702
|
artikel
|
| 26 |
Current Understanding of the Equivalence Evaluations for In Vitro Tests on Generic Dry Powder Inhaler Drug Products in Japan
|
Kuribayashi, Ryosuke
|
|
2019
|
|
6 |
p. 743-745
|
artikel
|
| 27 |
Development and Validation of a Length- and Habitus-Based Method of Ideal and Lean Body Weight Estimation for Adults Requiring Urgent Weight-Based Medical Intervention
|
Wells, Mike
|
|
|
|
6 |
p. 841-853
|
artikel
|
| 28 |
Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus Nephritis
|
Abd Rahman, Azrin N.
|
|
2017
|
|
6 |
p. 993-1004
|
artikel
|
| 29 |
Dose Escalation Study to Assess the Pharmacokinetic Parameters of a Nano-amorphous Oral Sirolimus Formulation in Healthy Volunteers
|
Basa-Dénes, Orsolya
|
|
2019
|
|
6 |
p. 777-785
|
artikel
|
| 30 |
Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
|
Zurth, Christian
|
|
2019
|
|
6 |
p. 747-759
|
artikel
|
| 31 |
Dual Inhibition of CYP3A4 by Voriconazole and Clarithromycin Influences Tacrolimus Pharmacokinetics: Case Series Study
|
Hirai, Toshinori
|
|
|
|
6 |
p. 889-893
|
artikel
|
| 32 |
Effect of Dietary Doses of Quercetin on Hepatic Drug Metabolizing Enzymes in Spontaneously Hypertensive Rats
|
Elbarbry, Fawzy
|
|
2019
|
|
6 |
p. 761-770
|
artikel
|
| 33 |
Effect of Gambogenic Acid on Cytochrome P450 1A2, 2B1 and 2E1, and Constitutive Androstane Receptor in Rats
|
Sun, Jing
|
|
2018
|
|
6 |
p. 655-664
|
artikel
|
| 34 |
Effect of Genetic Polymorphisms on the Pharmacokinetics of Deferasirox in Healthy Chinese Subjects and an Artificial Neural Networks Model for Pharmacokinetic Prediction
|
Chen, Jinliang
|
|
|
|
6 |
p. 761-770
|
artikel
|
| 35 |
Effect of Ginkgo Leaf Tablets on the Pharmacokinetics of Amlodipine in Rats
|
Wang, Rong
|
|
2015
|
|
6 |
p. 825-833
|
artikel
|
| 36 |
Effect of Long-term In Vitro Lithium Exposure on mRNA Levels of Claudin-3, CYP1A1, ABCG2 and GSTM3 Genes in the hCMEC/D3 Human Brain Endothelial Cell Line
|
Shawahna, Ramzi
|
|
2017
|
|
6 |
p. 1013-1017
|
artikel
|
| 37 |
Effect of Moderate Malnutrition on the Pharmacokinetics of Etoposide and Vincristine in Freshly Weaned Rats
|
Garg, Megha
|
|
|
|
6 |
p. 657-663
|
artikel
|
| 38 |
Effect of Multi Drug Resistance Protein 4 (MRP4) Inhibition on the Pharmacokinetics and Pharmacodynamics of Ciprofloxacin in Normal and Rats with LPS-Induced Inflammation
|
Prasad, V. Gangadhara N. V.
|
|
2015
|
|
6 |
p. 733-741
|
artikel
|
| 39 |
Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Safety, and Tolerability of Roxadustat in Healthy Subjects
|
Groenendaal-van de Meent, Dorien
|
|
2018
|
|
6 |
p. 685-692
|
artikel
|
| 40 |
Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes
|
AlRabiah, Haitham
|
|
2018
|
|
6 |
p. 707-713
|
artikel
|
| 41 |
Effect of 22 Novel Cytochrome P450 2D6 (CYP2D6) Variants Found in the Chinese Population on Hemangeol Metabolism In Vitro
|
Liang, Bingqing
|
|
2015
|
|
6 |
p. 759-765
|
artikel
|
| 42 |
Effect of Verapamil, a P-glycoprotein-1 and Cytochrome P450 3A4 Inhibitor, on Pharmacokinetics and Metabolic Stability of Ripretinib: A Drug–Drug Interaction Study in Rats
|
Mudavath, Shyamala
|
|
|
|
6 |
p. 733-746
|
artikel
|
| 43 |
Effects of Animal Strain, Dose, and Cotreatment with Saikosaponin b2 on the Pharmacokinetics of Saikosaponin a in Rats
|
Fu, Ruijia
|
|
2019
|
|
6 |
p. 827-836
|
artikel
|
| 44 |
Effects of UGT1A1 Polymorphism, Gender and Triglyceride on the Pharmacokinetics of Telmisartan in Chinese Patients with Hypertension: A Population Pharmacokinetic Analysis
|
Huang, Lu
|
|
2019
|
|
6 |
p. 797-806
|
artikel
|
| 45 |
Enhancement of Dissolution Rate and Intestinal Stability of Clopidogrel Hydrogen Sulfate
|
Bali, Dina E.
|
|
2015
|
|
6 |
p. 807-818
|
artikel
|
| 46 |
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
|
Kinvig, Hannah
|
|
|
|
6 |
p. 855-868
|
artikel
|
| 47 |
Evaluating the Feasibility of Use of a Foreign Reference Product for Generic Drug Applications: A Retrospective Pilot Study
|
Wang, Yi-lin
|
|
2017
|
|
6 |
p. 935-942
|
artikel
|
| 48 |
Evaluation of FOCEI and SAEM Estimation Methods in Population Pharmacokinetic Analysis Using NONMEM® Across Rich, Medium, and Sparse Sampling Data
|
Sukarnjanaset, Waroonrat
|
|
2018
|
|
6 |
p. 729-736
|
artikel
|
| 49 |
Evaluation of Strategies for the Assessment of Drug–Drug Interactions Involving Cytochrome P450 Enzymes
|
Reinen, Jelle
|
|
2018
|
|
6 |
p. 737-750
|
artikel
|
| 50 |
Further Assessment of the Relay Hepatocyte Assay for Determination of Intrinsic Clearance of Slowly Metabolised Compounds Using Radioactivity Monitoring and LC–MS Methods
|
Murgasova, Renata
|
|
2019
|
|
6 |
p. 817-826
|
artikel
|
| 51 |
Generic Drug Product Development in Japan: Regulatory Updates During 2014–2019 and the Future
|
Kasuga, Miho
|
|
|
|
6 |
p. 711-719
|
artikel
|
| 52 |
High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect
|
Golocorbin-Kon, Svetlana
|
|
2017
|
|
6 |
p. 1005-1011
|
artikel
|
| 53 |
Impact of the CYP3A5*1 Allele on the Pharmacokinetics of Tacrolimus in Japanese Heart Transplant Patients
|
Uno, Takaya
|
|
2018
|
|
6 |
p. 665-673
|
artikel
|
| 54 |
Inhibition of Rat CYP1A2 and CYP2C11 by Honokiol, a Component of Traditional Chinese Medicine
|
Li, Jing
|
|
2019
|
|
6 |
p. 787-796
|
artikel
|
| 55 |
Interaction of Citrus Juices with Cyclosporine: Systematic Review and Meta-Analysis
|
Sridharan, Kannan
|
|
2016
|
|
6 |
p. 665-673
|
artikel
|
| 56 |
Interchangeability between Generic and Reference Products: Limits of Average Bioequivalence Methodology
|
Lechat, Philippe
|
|
|
|
6 |
p. 777-787
|
artikel
|
| 57 |
Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures
|
Mangas-Sanjuan, Victor
|
|
2015
|
|
6 |
p. 795-806
|
artikel
|
| 58 |
Investigation of the Interaction Between Human Serum Albumin and Two Drugs as Binary and Ternary Systems
|
Abdollahpour, Nooshin
|
|
2015
|
|
6 |
p. 705-721
|
artikel
|
| 59 |
In Vitro Monitoring of the Mitochondrial Beta-Oxidation Flux of Palmitic Acid and Investigation of Its Pharmacological Alteration by Therapeutics
|
Murgasova, Renata
|
|
2018
|
|
6 |
p. 675-684
|
artikel
|
| 60 |
Involvement of Autophagy in the Protective Effects of Ginsenoside Rb1 in a Rat Model of Traumatic Brain Injury
|
Zou, Shufeng
|
|
|
|
6 |
p. 869-877
|
artikel
|
| 61 |
Is Monitoring of the Intracellular Active Metabolite Levels of Nucleobase and Nucleoside Analogs Ready for Precision Medicine Applications?
|
Huang, Shenjia
|
|
|
|
6 |
p. 761-775
|
artikel
|
| 62 |
Lack of Drug–Drug Interaction Between Cimetidine, a Renal Transporter Inhibitor, and Imeglimin, a Novel Oral Antidiabetic Drug, in Healthy Volunteers
|
Chevalier, Clémence
|
|
|
|
6 |
p. 725-733
|
artikel
|
| 63 |
Metabolic Profiling of Glabridin in Rat Plasma, Urine, Bile, and Feces After Intragastric and Intravenous Administration
|
Liu, Shundi
|
|
|
|
6 |
p. 879-887
|
artikel
|
| 64 |
Nicotine Population Pharmacokinetics in Healthy Adult Smokers: A Retrospective Analysis
|
Marchand, Mathilde
|
|
2017
|
|
6 |
p. 943-954
|
artikel
|
| 65 |
Nose-to-Brain Delivery of Diazepam from an Intranasal Aqua-Triggered In-Situ (ATIS) Gelling Microemulsion: Monitoring Brain Uptake by Microdialysis
|
Bachhav, Sagar S.
|
|
|
|
6 |
p. 785-799
|
artikel
|
| 66 |
Nutritional Status Differentially Alters Cytochrome P450 3A4 (CYP3A4) and Uridine 5′-Diphospho-Glucuronosyltransferase (UGT) Mediated Drug Metabolism: Effect of Short-Term Fasting and High Fat Diet on Midazolam Metabolism
|
Lammers, Laureen A.
|
|
2018
|
|
6 |
p. 751-767
|
artikel
|
| 67 |
Observation of Clinically Relevant Drug Interaction in Chimeric Mice with Humanized Livers: The Case of Valproic Acid and Carbapenem Antibiotics
|
Suzuki, Eiko
|
|
2017
|
|
6 |
p. 965-972
|
artikel
|
| 68 |
Oral Antibiotics in Patients with Short Bowel Syndrome: Do or Don’t?
|
Gompelman, Michelle
|
|
|
|
6 |
p. 821-823
|
artikel
|
| 69 |
Oral Antibiotics in Patients with Short Bowel Syndrome: Hurdles and Caveats
|
Law, Lawrence Siu-Chun
|
|
|
|
6 |
p. 825-826
|
artikel
|
| 70 |
Pharmacokinetic Basis of the Hydroxychloroquine Response in COVID-19: Implications for Therapy and Prevention
|
Tarek, Mohammad
|
|
|
|
6 |
p. 715-723
|
artikel
|
| 71 |
Pharmacokinetic Profiling of Butylidenephthalide and Alisol B in Danggui-Shaoyao-San in Rats
|
Wu, Hui-fei
|
|
2018
|
|
6 |
p. 645-653
|
artikel
|
| 72 |
Pharmacokinetic Properties of S-oxiracetam After Single and Multiple Intravenous Infusions in Healthy Volunteers
|
Liang, Dahu
|
|
|
|
6 |
p. 793-805
|
artikel
|
| 73 |
Pharmacokinetics and Monte Carlo Dosing Simulations of Imipenem in Critically Ill Patients with Life-Threatening Severe Infections During Support with Extracorporeal Membrane Oxygenation
|
Jaruratanasirikul, Sutep
|
|
|
|
6 |
p. 735-747
|
artikel
|
| 74 |
Pharmacokinetics and Safety of Long-Acting Release Formulations of Pasireotide (SOM230) in a Male Population Who Are Hyperendemic Hepatitis B/C and Chronic Kidney Disease: An Open-Label, Phase I Study
|
Huang, Chun-Jui
|
|
|
|
6 |
p. 665-674
|
artikel
|
| 75 |
Pharmacokinetics, Mass Balance and Metabolism of [14C]HSK21542, a Novel Kappa Opioid Receptor Agonist, in Humans
|
Yuan, Jin-jie
|
|
|
|
6 |
p. 723-731
|
artikel
|
| 76 |
Pharmacokinetics of Curcumin Diethyl Disuccinate, a Prodrug of Curcumin, in Wistar Rats
|
Bangphumi, Kunan
|
|
2015
|
|
6 |
p. 777-785
|
artikel
|
| 77 |
Pharmacokinetics of Glycopyrronium Following Repeated Once-Daily Inhalation in Healthy Chinese Subjects
|
Sechaud, Romain
|
|
2015
|
|
6 |
p. 723-731
|
artikel
|
| 78 |
Pharmacokinetics of Oral Rebaudioside A in Patients with Type 2 Diabetes Mellitus and Its Effects on Glucose Homeostasis: A Placebo-Controlled Crossover Trial
|
Simoens, Caroline
|
|
|
|
6 |
p. 827-839
|
artikel
|
| 79 |
Pharmacokinetics of Single Ascending Doses and Multiple Doses of 20(S)-Ginsenoside Rg3 in Chinese Healthy Volunteers
|
Zhao, Qian
|
|
2015
|
|
6 |
p. 845-853
|
artikel
|
| 80 |
Pharmacokinetics of Synthetic Cathinones Found in Bath Salts in Mouse Brain and Plasma Using High-Pressure Liquid Chromatography–Tandem Mass Spectrometry
|
Gearlds, Courtney
|
|
|
|
6 |
p. 771-778
|
artikel
|
| 81 |
Pharmacokinetics of the Novel, Selective, Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone in Healthy Volunteers: Results from an Absolute Bioavailability Study and Drug–Drug Interaction Studies In Vitro and In Vivo
|
Heinig, Roland
|
|
2018
|
|
6 |
p. 715-727
|
artikel
|
| 82 |
Pharmacokinetics, Tolerability, and Safety of Single and Multiple Omecamtiv Mecarbil Doses in Healthy Japanese and Caucasian Subjects
|
Trivedi, Ashit
|
|
|
|
6 |
p. 759-770
|
artikel
|
| 83 |
Phase 1 Study to Assess the Safety and Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Subjects Without Cystic Fibrosis With Moderate Hepatic Impairment
|
Viswanathan, Lakshmi
|
|
|
|
6 |
p. 817-825
|
artikel
|
| 84 |
Physiologically Based Pharmacokinetic Modelling and Prediction of Metformin Pharmacokinetics in Renal/Hepatic-Impaired Young Adults and Elderly Populations
|
Rhee, Su-jin
|
|
2017
|
|
6 |
p. 973-980
|
artikel
|
| 85 |
Physiologically-Based Pharmacokinetic Modelling of Entrectinib Parent and Active Metabolite to Support Regulatory Decision-Making
|
Djebli, Nassim
|
|
|
|
6 |
p. 779-791
|
artikel
|
| 86 |
Population Pharmacokinetic Analysis from First-in-Human Data for HDAC Inhibitor, REC-2282 (AR-42), in Patients with Solid Tumors and Hematologic Malignancies: A Case Study for Evaluating Flat vs. Body Size Normalized Dosing
|
Liva, Sophia
|
|
|
|
6 |
p. 807-816
|
artikel
|
| 87 |
Population Pharmacokinetic Analysis of Vancomycin in Patients with Solid or Hematological Malignancy in Relation to the Quick Sequential Organ Failure Assessment Scores
|
Tsuda, Yasumasa
|
|
|
|
6 |
p. 647-655
|
artikel
|
| 88 |
Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization
|
Thémans, Pauline
|
|
|
|
6 |
p. 703-713
|
artikel
|
| 89 |
Population Pharmacokinetics of Inhaled Fluticasone Furoate and Vilanterol in Subjects with Chronic Obstructive Pulmonary Disease
|
Siederer, Sarah
|
|
2015
|
|
6 |
p. 743-758
|
artikel
|
| 90 |
Population Pharmacokinetics of MYL-1402O, a Proposed Biosimilar to Bevacizumab and Reference Product (Avastin®) in Patients with Non-squamous Non-small Cell Lung Cancer
|
Owen, Joel S.
|
|
|
|
6 |
p. 675-689
|
artikel
|
| 91 |
Population Pharmacokinetics to Model the Time-Varying Clearance of the PEGylated Asparaginase Oncaspar® in Children with Acute Lymphoblastic Leukemia
|
Würthwein, Gudrun
|
|
2017
|
|
6 |
p. 955-963
|
artikel
|
| 92 |
Potential Influence of Centrally Acting Herbal Drugs on Transporters at the Blood–Cerebrospinal Fluid Barrier and Blood–Brain Barrier
|
Kibathi, Lilian W.
|
|
2018
|
|
6 |
p. 619-635
|
artikel
|
| 93 |
Potential Risk of Food-Drug Interactions: Citrus Polymethoxyflavones and Flavanones as Inhibitors of the Organic Anion Transporting Polypeptides (OATP) 1B1, 1B3, and 2B1
|
Bajraktari-Sylejmani, Gzona
|
|
|
|
6 |
p. 809-815
|
artikel
|
| 94 |
Preclinical Pharmacokinetics and Pharmacodynamics of Pinometostat (EPZ-5676), a First-in-Class, Small Molecule S-Adenosyl Methionine Competitive Inhibitor of DOT1L
|
Waters, Nigel J.
|
|
2017
|
|
6 |
p. 891-901
|
artikel
|
| 95 |
Predictability of Capillary Blood Spot Toward Venous Whole Blood Sampling for Therapeutic Drug Monitoring of Tacrolimus in Solid Organ Transplant Recipients
|
Gallant, Jaryd
|
|
2019
|
|
6 |
p. 729-741
|
artikel
|
| 96 |
Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling Methods
|
Mahmood, Iftekhar
|
|
2015
|
|
6 |
p. 767-775
|
artikel
|
| 97 |
Prediction of the Oral Bioavailability Correlation Between Humans and Preclinical Animals
|
Beheshti, Samin
|
|
|
|
6 |
p. 771-783
|
artikel
|
| 98 |
Presence of an H+/Quinidine Antiport System in Madin–Darby Canine Kidney Cells
|
Fukao, Miki
|
|
2015
|
|
6 |
p. 819-824
|
artikel
|
| 99 |
Proposing the Use of Partial AUC as an Adjunctive Measure in Establishing Bioequivalence Between Deltoid and Gluteal Administration of Long-Acting Injectable Antipsychotics
|
Lee, Lik Hang N.
|
|
2016
|
|
6 |
p. 659-664
|
artikel
|
| 100 |
Results From Drug–Drug Interaction Studies In Vitro and In Vivo Investigating the Inhibitory Effect of Finerenone on the Drug Transporters BCRP, OATP1B1, and OATP1B3
|
Heinig, Roland
|
|
|
|
6 |
p. 803-815
|
artikel
|
| 101 |
Retraction Note to: Changes of Absorptive and Secretory Transporting System of (1 → 3) β-D-glucan Based on Efflux Transporter in Indomethacin-induced Rat
|
Iida, Aiko
|
|
2018
|
|
6 |
p. 769
|
artikel
|
| 102 |
Retraction Note to: Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes
|
Natsui, Kiyohi
|
|
2019
|
|
6 |
p. 853
|
artikel
|
| 103 |
Severe 5-Fluorouracil-Associated Gastrointestinal Toxicity Unexplained by Dihydropyrimidine Dehydrogenase Deficiency and Renal Impairment: Should We Be Investigating Other Elimination Pathways to Assess the Risk of 5-Fluorouracil Toxicity?
|
Jeong, Soo Hee
|
|
|
|
6 |
p. 817-820
|
artikel
|
| 104 |
Single Dose Oral and Intravenous Pharmacokinetics and Tissue Distribution of a Novel Hesperetin Derivative MTBH in Rats
|
Shen, Chenlin
|
|
2015
|
|
6 |
p. 675-688
|
artikel
|
| 105 |
Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects
|
Lorier, Marianela
|
|
2015
|
|
6 |
p. 787-793
|
artikel
|
| 106 |
The Effects of CYP3A5 Genetic Polymorphisms on Serum Tacrolimus Dose-Adjusted Concentrations and Long-Term Prognosis in Chinese Heart Transplantation Recipients
|
Liu, Bing-yang
|
|
2019
|
|
6 |
p. 771-776
|
artikel
|
| 107 |
The Effects of 16-HETE Enantiomers on Hypertrophic Markers in Human Fetal Ventricular Cardiomyocytes, RL-14 Cells
|
Hidayat, Rahmat
|
|
|
|
6 |
p. 709-722
|
artikel
|
| 108 |
The Influence of Paracetamol on the Penetration of Sorafenib and Sorafenib N-Oxide Through the Blood–Brain Barrier in Rats
|
Karbownik, Agnieszka
|
|
|
|
6 |
p. 801-808
|
artikel
|
| 109 |
The Pharmacokinetic Profile of Palovarotene: An Open-Label Phase I Trial Investigating the Effect of Food and Potential for Drug–Drug Interaction in Healthy Participants
|
Marino, Rose
|
|
|
|
6 |
p. 691-707
|
artikel
|
| 110 |
Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies
|
Dash, Ranjeet Prasad
|
|
2017
|
|
6 |
p. 915-933
|
artikel
|
| 111 |
The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes
|
Mikov, Momir
|
|
2017
|
|
6 |
p. 881-890
|
artikel
|
| 112 |
Unraveling the Effects of Acute Inflammation on Pharmacokinetics: A Model-Based Analysis Focusing on Renal Glomerular Filtration Rate and Cytochrome P450 3A4-Mediated Metabolism
|
Liu, Feiyan
|
|
|
|
6 |
p. 623-631
|
artikel
|
| 113 |
Use of Clearance Concepts to Simulate Impact of Interleukin-6 on Drug Elimination Governed by Cytochromes P450 3A4 and Glomerular Filtration Rate
|
Chen, Xiang
|
|
|
|
6 |
p. 619-621
|
artikel
|
| 114 |
Vancomycin Pharmacokinetics in Patients with Advanced Cancer Near End of Life
|
Nakayama, Hirokazu
|
|
2019
|
|
6 |
p. 837-843
|
artikel
|
Tijdschrift beschrijving